Biolife Solutions (BLFS) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Biolife Solutions (BLFS) over the last 16 years, with Q2 2025 value amounting to -$15.8 million.
- Biolife Solutions' Net Income towards Common Stockholders rose 2355.81% to -$15.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year increase of 9637.15%. This contributed to the annual value of -$8.8 million for FY2024, which is 8675.69% up from last year.
- Latest data reveals that Biolife Solutions reported Net Income towards Common Stockholders of -$15.8 million as of Q2 2025, which was up 2355.81% from -$448000.0 recorded in Q1 2025.
- In the past 5 years, Biolife Solutions' Net Income towards Common Stockholders registered a high of $14.6 million during Q4 2024, and its lowest value of -$72.9 million during Q2 2022.
- Over the past 5 years, Biolife Solutions' median Net Income towards Common Stockholders value was -$10.3 million (recorded in 2022), while the average stood at -$13.9 million.
- As far as peak fluctuations go, Biolife Solutions' Net Income towards Common Stockholders plummeted by 1315949.37% in 2022, and later surged by 20922.13% in 2024.
- Quarter analysis of 5 years shows Biolife Solutions' Net Income towards Common Stockholders stood at -$15.7 million in 2021, then crashed by 212.41% to -$49.2 million in 2022, then skyrocketed by 72.79% to -$13.4 million in 2023, then skyrocketed by 209.22% to $14.6 million in 2024, then crashed by 208.36% to -$15.8 million in 2025.
- Its Net Income towards Common Stockholders was -$15.8 million in Q2 2025, compared to -$448000.0 in Q1 2025 and $14.6 million in Q4 2024.